Ignite Creation Date:
2024-05-06 @ 1:33 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04055493
Status:
RECRUITING
Last Update Posted:
2023-05-15
First Post:
2019-07-22
Brief Title:
Adj Marker-adjusted Personalized Therapy Comparing ETRibociclib vs Chemotherapy in Intermediate Risk HRHER2- EBC
Sponsor:
Organization:
West German Study Group